We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lower Mortality Rates Shown with LDCT Screening

By HospiMedica International staff writers
Posted on 24 Oct 2017
A new study has shown that by combining Low-Dose CT (LDCT) lung cancer screening program with robust programs that help people stop smoking can reduce mortality rates, and be cost-effective.

The researchers used OncoSim-LC, a microsimulation model to compare screening scenarios with smoking-cessation, to those without a cessation program, and projected this over 20 years.

The findings were presented by researchers from the McMaster University (Hamilton, ON, Canada) at the 18th World Conference on Lung Cancer (WCLC) organized by the International Association for the Study of Lung Cancer (IASLC), in Yokohama, Japan. More...
The results of OncoSim-LC microsimulation model study showed that by adding a smoking-cessation program to an organized LDCT screening program was relatively cost effective, and resulted in significantly fewer deaths.

Additional research is required to determine the structure of such joint programs, to determine the detailed economic requirements, and to ensure that participants continue to adhere to both LDCT and smoking cessation programs.

Dr. William Evans, from the McMaster University, said, "To achieve the maximal benefits of a LDCT screening program, it is essential to incorporate a robust smoking cessation intervention. In my long career as an oncologist, I have not been able to save any patients from advanced non-small cell lung cancer. I believe that an organized lung screening program can be used to provide teachable moments for heavy smokers and, ultimately, save lives."

Related Links:
McMaster University


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Gas Analyzer
GE SAM
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.